Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12611000783921
Ethics application status
Approved
Date submitted
25/07/2011
Date registered
27/07/2011
Date last updated
15/05/2014
Type of registration
Retrospectively registered
Titles & IDs
Public title
Cardiovascular Magnetic Resonance Imaging study assessing myocardial ischemia in patients with end-stage renal disease and renal transplant - post renal transplant cohort
Query!
Scientific title
Study of myocardial ischemia post renal transplant as assessed by Cardiac MRI in patients with end-stage renal disease
Query!
Secondary ID [1]
262373
0
None
Query!
Universal Trial Number (UTN)
U1111-1122-1549
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Myocardial Ischaemia in patients with renal disease
268078
0
Query!
Condition category
Condition code
Cardiovascular
268225
268225
0
0
Query!
Coronary heart disease
Query!
Renal and Urogenital
268226
268226
0
0
Query!
Kidney disease
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Framingham's risk score at baseline (race, age, smoking history, family history of cardiac disease, cardiac risk factors)
Blood tests at baseline - biochemical markers (hsCRP); markers of fibrosis (MMP); troponin T, BNP and homocysteine levels.
Cardiac MRI at baseline - cine images; Blood oxygen level dependent MRI (BOLD) rest and stress using adenosine 140mcg/kg/min for 3-6 minutes; 1st pass perfusion imaging after rapid bolus Gd-DTPA 0.045 mmol/kg body weight, then after 15 minutes a further 0.045 mmol/kg Gd-DTPA would be given to obtain resting perfusion; finally delayed enhancement CMR.
Follow up via phone call at 6, 12 and 24 months for Major Adverse Cardiac Events - including angina, myocardial infarction, rehospitalisation with cardiac event, cerebrovascular event, heart failure and death.
Query!
Intervention code [1]
267041
0
Early detection / Screening
Query!
Intervention code [2]
267051
0
Diagnosis / Prognosis
Query!
Comparator / control treatment
nil
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
269284
0
Major Adverse Cardiac Events including angina, myocardial infarction, rehospitalisation with cardiac event, cerebrovascular event, heart failure and death assessed by reviewing patients medical records and phone call
Query!
Assessment method [1]
269284
0
Query!
Timepoint [1]
269284
0
6, 12 and 24 months
Query!
Secondary outcome [1]
279296
0
BOLD, Delayed Enhancement-CMR and first pass perfusion as predictors of Major Adverse Cardiac Events
Query!
Assessment method [1]
279296
0
Query!
Timepoint [1]
279296
0
6, 12 and 24 months
Query!
Secondary outcome [2]
279320
0
Troponin T and hsCRP as predictors of Major Adverse Cardiac Events
Query!
Assessment method [2]
279320
0
Query!
Timepoint [2]
279320
0
6, 12 and 24 months
Query!
Eligibility
Key inclusion criteria
all patients who have undergone renal transplant >3 months ago; eGFR >45mls/min
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
inability to give informed consent; extreme claustrophobia; implantable cardiac devices and other contra-indications to MRI; asthma or other reversible bronchospasm; patients on theophylline; inability to lie flat for 1hr; eGFR <45mls/min;
Query!
Study design
Purpose of the study
Diagnosis
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
7/07/2011
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
80
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
267512
0
Hospital
Query!
Name [1]
267512
0
Flinders Medical Centre
Query!
Address [1]
267512
0
1 Flinders Drive
BEDFORD PARK
SA 5042
Query!
Country [1]
267512
0
Australia
Query!
Primary sponsor type
Individual
Query!
Name
Professor Joseph Selvanayagam
Query!
Address
Dept Cardiovascular Medicine
Flinders Medical Centre
1 Flinders Drive
BEDFORD PARK
SA 5042
Query!
Country
Australia
Query!
Secondary sponsor category [1]
266554
0
None
Query!
Name [1]
266554
0
Query!
Address [1]
266554
0
Query!
Country [1]
266554
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
269479
0
Southern Adelaide Clinical Human Research Ethics Committee
Query!
Ethics committee address [1]
269479
0
1 Flinders Drive
BEDFORD PARK
SA 5042
Query!
Ethics committee country [1]
269479
0
Australia
Query!
Date submitted for ethics approval [1]
269479
0
09/09/2010
Query!
Approval date [1]
269479
0
14/02/2011
Query!
Ethics approval number [1]
269479
0
1/10/0380
Query!
Summary
Brief summary
This project is designed to assess myocardial ischemia in various populations of patients with renal disease. These cohorts of patients have significant cardiovascular morbidity and mortality. It is believed that apart from epicardial coronary disease, they also have microvascular or small vessel ischemia. Dialysis is thought to be a major contributor in acceleration of their cardiovascular disease, however even after renal transplantation, there cardiovascular morbidity and mortality does not mirror the general population. We are going to assess myocardial ischemia using cardiac MRI and blood oxygen level dependent imaging. This uses intrinsic contrast of deoxy-hemoglobin to assess ischemia. We are going to assess it in patients on dialysis regardless of their cardiovascular symptoms as this group of patients have significant disease despite lack of traditional cardiac symptoms. We are also going to look at patients being evaluated for renal transplant. In this population, we can directly compare this relatively new technique with traditional method of ischemia assessment. We believe this technique will provided added information to already existing imaging modalities as it looks at oxygenation of the myocardium, which precedes development of ischemia. Our third cohort, evaluates patients after their renal transplant, examining markers that may predict cardiovascular morbidity and mortality in this group. This trial is the post transplant cohort and is linked to trial ACTRN12611000786998 and ACTRN12611000785909
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
32744
0
Query!
Address
32744
0
Query!
Country
32744
0
Query!
Phone
32744
0
Query!
Fax
32744
0
Query!
Email
32744
0
Query!
Contact person for public queries
Name
15991
0
Christine Edwards
Query!
Address
15991
0
Flinders Clinical Research
Level 3A
Mark Oliphant Building
Laffer Drive
BEDFORD PARK
SA 5042
Query!
Country
15991
0
Australia
Query!
Phone
15991
0
+61 8 8201 5656
Query!
Fax
15991
0
Query!
Email
15991
0
[email protected]
Query!
Contact person for scientific queries
Name
6919
0
Professor Joseph Selvanayagam
Query!
Address
6919
0
Dept Cardiovascular Medicine
Flinders Medical Centre
1 Flinders Drive
BEDFORD PARK
SA 5042
Query!
Country
6919
0
Australia
Query!
Phone
6919
0
+61 8 8404 3971
Query!
Fax
6919
0
Query!
Email
6919
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF